Reference:
FLCCC Alliance. (2021). I-MASK+ prophylaxis & early outpatient treatment protocol for COVID-19. Retrieved from www.flccc.net
Summary:
The FLCCC Alliance’s I-MASK+ protocol provides guidelines for the prophylaxis and early outpatient treatment of COVID-19. It recommends the use of Ivermectin, along with Vitamin D3, Vitamin C, Quercetin, Zinc, Melatonin, and Aspirin for high-risk individuals and post-exposure prophylaxis. Dosages are tailored based on body weight, ensuring effective treatment over a maximum of five days. Additionally, the protocol advises behavioural measures such as wearing masks, maintaining distance, and hand hygiene to mitigate virus transmission. Scientific evidence supports the efficacy of Ivermectin, highlighting its antiviral and anti-inflammatory properties observed in clinical trials. The protocol aims to provide comprehensive care while emphasising the importance of professional medical advice. Further resources and updates regarding the I-MASK+ protocol can be found on the FLCCC website, encouraging patients and healthcare providers to stay informed about emerging data. The document underscores the need for individualised treatment plans based on clinical judgement, while also serving as an educational tool for potentially beneficial therapies against COVID-19.